Bangkok Dusit Medical Services Public Company Limited

SET-BDMS

Basic

Market Cap
THB 417.17B
EV
THB 424.57B
Shares Out
15.89B
Revenue
THB 104.73B
Employees
—

Margins

Gross
37.91%
EBITDA
23.89%
Operating
18.75%
Pre-Tax
18.57%
Net
14.3%
FCF
13.19%

Returns (5Yr Avg)

ROA
8.16%
ROTA
12.85%
ROE
12.59%
ROCE
11.11%
ROIC
8.41%

Valuation (TTM)

P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—

Valuation (NTM)

Price Target
THB 34.85
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—

Financial Health

Cash
THB 13.02B
Net Debt
THB 3,667.8M
Debt/Equity
0.16
EBIT/Interest
39.66

Growth (CAGR)

Rev 3Yr
17.62%
Rev 5Yr
5.98%
Rev 10Yr
7.1%
Dil EPS 3Yr
35.78%
Dil EPS 5Yr
0.01%
Dil EPS 10Yr
8.61%
Rev Fwd 2Yr
8.53%
EBITDA Fwd 2Yr
11.25%
EPS Fwd 2Yr
10.28%
EPS LT Growth Est
35%

Dividends

Yield
—
Payout
111.39%
DPS
THB 1.05
DPS Growth 3Yr
24.05%
DPS Growth 5Yr
26.83%
DPS Growth 10Yr
18.04%
DPS Growth Fwd 2Yr
7.23%

Metric	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	LTM
Operating Revenues						82,722.6	68,074.1	74,451.3	91,933.6	100,852.6	103,451.7
Other Revenues, Total			—		—	—	—	1,262.6	1,034	1,257.8	1,275.5
Total Revenues						82,722.6	68,074.1	75,714	92,967.6	102,110.4	104,727.2
Total Revenues % Chg.						6.9%	-17.7%	11.2%	22.8%	9.8%	11.3%
Cost of Goods Sold, Total						54,276.7	46,371.2	49,496.9	58,329.4	63,412.1	65,026
Gross Profit						28,445.9	21,702.9	26,217.1	34,638.3	38,698.3	39,701.2
Selling General & Admin Expenses, Total						17,446.6	14,160.9	14,993.7	17,654.6	19,806	20,066
Other Operating Expenses, Total						17,446.6	14,160.9	14,993.7	17,654.6	19,806	20,066
Operating Income						10,999.4	7,542	11,223.4	16,983.7	18,892.3	19,635.2
Interest Expense, Total						-928.8	-870.9	-728.5	-632.1	-546.6	-495.1
Interest And Investment Income						119.4	44.5	77.7	87.9	216.9	236.2
Net Interest Expenses						-809.4	-826.4	-650.7	-544.1	-329.7	-259
Income (Loss) On Equity Invest.						1,022.4	272.9	21.1	41.8	89.4	68
Other Non Operating Income (Expenses)	—	—		—		1,051.2	983.1	—	—	—	—
EBT, Excl. Unusual Items						12,263.6	7,971.6	10,593.7	16,481.4	18,652	19,444.3
Gain (Loss) On Sale Of Investments	—				—	7,619	2,429	—	—	—	—
EBT, Incl. Unusual Items						19,882.6	10,400.6	10,593.7	16,481.4	18,652	19,444.3
Income Tax Expense						3,873.5	2,751.4	2,103.4	3,227.2	3,754.5	3,914.7
Earnings From Continuing Operations						16,009.2	7,649.3	8,490.4	13,254.2	14,897.5	15,529.6
Minority Interest						-492	-435	-554.3	-648	-522.2	-548.7
Net Income						15,517.2	7,214.2	7,936.1	12,606.2	14,375.3	14,981
Net Income to Common Incl Extra Items						15,517.2	7,214.2	7,936.1	12,606.2	14,375.3	14,981
Net Income to Common Excl. Extra Items						15,517.2	7,214.2	7,936.1	12,606.2	14,375.3	14,981
Total Shares Outstanding						15,892	15,892	15,892	15,892	15,892	15,892
Weighted Avg. Shares Outstanding						15,742.8	15,892	15,892	15,892	15,892	15,892
Weighted Avg. Shares Outstanding Dil						15,742.8	15,892	15,892	15,892	15,892	15,892
EPS						1	0.5	0.5	0.8	0.9	0.9
EPS Diluted						1	0.5	0.5	0.8	0.9	0.9
EBITDA						16,751.5	13,497.7	17,073.1	22,512	24,337.1	25,020.6
Effective Tax Rate						19.5%	26.5%	19.9%	19.6%	20.1%	20.1%